Showing results (1571-1580 of 1,596) with videos related to

Sort By:
Pageof 160
Journal of the National Cancer Institute|March 7, 2015
The contributions of breast density and common genetic variation to breast cancer riskCeline M Vachon, V Shane Pankratz, Christopher G Scott, et al.
ACS ES&T Air|March 12, 2026
The complex effects of reduced mobile source emissions on submicron particulate matter concentrations in Los AngelesBenjamin C Schulze, Christopher M Kenseth, Ryan X Ward, et al.
Current Cancer Drug Targets|January 21, 2011
Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trialsB C Potts, M X Albitar, K C Anderson, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|October 10, 2023
Outcomes of Extracorporeal Life Support Utilization for Pediatric Patients With COVID-19 InfectionsJillian C Jacobson, Mark L Ryan, Adam M Vogel, et al.
Nature Genetics|November 25, 2003
Mutations in the polyglutamine binding protein 1 gene cause X-linked mental retardationVera M Kalscheuer, Kristine Freude, Luciana Musante, et al.
Human Genetics|December 12, 2013
X-linked congenital ptosis and associated intellectual disability, short stature, microcephaly, cleft palate, digital and genital abnormalities define novel Xq25q26 duplication syndromeR S Møller, L R Jensen, S M Maas, et al.
The New England Journal of Medicine|August 3, 2007
Whole-genome analysis of sporadic amyotrophic lateral sclerosisTravis Dunckley, Matthew J Huentelman, David W Craig, et al.
Scientific Data|November 28, 2025
Sentinel-2 based estimates of rangeland fractional cover and canopy gap class for the western United StatesBrady W Allred, Sarah E McCord, Timothy J Assal, et al.
The Journal of Trauma and Acute Care Surgery|March 25, 2026
Consensus-based criteria for actionable hemorrhage in pediatric trauma: A Delphi studyMary S Kim, Aaron H Mun, Dylan W Arkowitz, et al.
European Heart Journal|August 30, 2025
Effectiveness of bivalent respiratory syncytial virus prefusion F protein-based vaccine in individuals with or without atherosclerotic cardiovascular disease: the DAN-RSV trialManan Pareek, Mats C Højbjerg Lassen, Niklas Dyrby Johansen, et al.
Pageof 160